LabCompass

Prakhar Srivastava

Medicine · The Ohio State University

Early career · publishing since 2018

Publications

15

Citations

181

Est. group size

~1

Recurring co-author estimate

Active years

9

Publishing since 2018

Research summary
AI-generated

Prakhar Srivastava's work centers on antibiotic-resistant bacterial infections, particularly Staphylococcus aureus and Pseudomonas aeruginosa, and how bacterial biofilms (protective slimy communities that bacteria form) contribute to hard-to-treat infections like diabetic foot ulcers. Research approaches include testing combination drug therapies, phage (virus-based) treatments, natural compounds, and nanoparticles as strategies to fight drug-resistant bacteria.

Antimicrobial resistance and drug combination therapiesBacterial biofilms and quorum sensing (bacterial communication)Diabetic foot ulcer infectionsAntibacterial nanoparticles and natural compoundsPhage therapy for resistant infections

Publication output has been modest and relatively steady over the last decade, averaging under 2 papers per year, with a slight uptick in 2024.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
172018: 2 publications182019: 2 publications192020: 2 publications202021: 1 publication212022: 2 publications222023: 1 publication232024: 3 publications3242025: 1 publication252026: 1 publication26
Recent publications
Publishes in
  • Pharmaceutics×2
  • Infectious Diseases and Therapy×2
  • Microbial Pathogenesis×1
  • The International Journal of Lower Extremity Wounds×1
  • Journal of Composites Science×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile